Viatris Sues Teva In US Over ‘Illegal Copaxone Scheme’
New Jersey Lawsuit Alleges ‘Series Of Tactics’ By Teva
Viatris’ Mylan has accused Teva of creating a perfect ‘playbook’ to delay Mylan’s launch of a generic version of its Copaxone blockbuster and then strangle uptake, something Mylan was vocal about years earlier, in a suit filed in a New Jersey court.
